#818 – The Industry Wire

July 17, 2026 Brian Casey 0 min read
  1. Biopharma firms ride high into Q2 earnings season. 
  2. UnitedHealthcare beats expectations with Q2 financials. 
  3. Are payors backing away from pledges to reform prior authorization? 
  4. U.S. Senate votes to save WISeR prior auth pilot project.
  5. Hospitals look for help to automate RCM processes. 
  6. FDA officials retreat from policy guidelines from previous officials. 
  7. Is data on ultrasound-directed gene therapy “too good to be true?”
  8. Deaths from coronary artery disease fall in U.S. 
  9. Editors at diabetes journal rebel after claiming censorship. 
  10. California farm linked to cyclosporiasis outbreak preps wider recall. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Prostate Cancer Imaging August 7, 2026

Could MRI Move the Needle in Prostate Cancer Workup? August 7, 2026

While many countries have added MRI to prostate cancer workup protocols to determine which patients really need the needle, pre-biopsy MRI is used in only about one-third of U.S. prostate cancer workups – why?

Radiologists August 6, 2026

Radiology Report Turnaround Slows August 6, 2026

Radiologists are taking much longer to interpret medical images than they did 10 years ago, and it’s a problem that appears to be getting worse.

Radiologists August 3, 2026

Rads Flee VA After Agency Banned Remote Work August 3, 2026

A new report claims that radiologists fled the VA healthcare system after the agency eliminated policies allowing remote work.